HRT Financial’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-46,726
| Closed | -$89K | – | 2222 |
|
2025
Q1 | $89K | Buy |
+46,726
| New | +$89K | ﹤0.01% | 1936 |
|
2024
Q1 | – | Sell |
-15,094
| Closed | -$18K | – | 2112 |
|
2023
Q4 | $18K | Buy |
+15,094
| New | +$18K | ﹤0.01% | 1877 |
|
2023
Q2 | – | Sell |
-148,681
| Closed | -$83K | – | 2196 |
|
2023
Q1 | $83K | Buy |
+148,681
| New | +$83K | ﹤0.01% | 1902 |
|
2022
Q4 | – | Sell |
-23,453
| Closed | -$7K | – | 2227 |
|
2022
Q3 | $7K | Sell |
23,453
-1,080,284
| -98% | -$322K | ﹤0.01% | 2374 |
|
2022
Q2 | $389K | Buy |
1,103,737
+1,078,469
| +4,268% | +$380K | ﹤0.01% | 1800 |
|
2022
Q1 | $18K | Sell |
25,268
-353,300
| -93% | -$252K | ﹤0.01% | 2568 |
|
2021
Q4 | $855K | Buy |
+378,568
| New | +$855K | ﹤0.01% | 1115 |
|
2021
Q3 | – | Sell |
-62,446
| Closed | -$236K | – | 2957 |
|
2021
Q2 | $236K | Sell |
62,446
-201,535
| -76% | -$762K | ﹤0.01% | 2196 |
|
2021
Q1 | $893K | Buy |
+263,981
| New | +$893K | 0.01% | 1122 |
|
2019
Q4 | – | Sell |
-16,367
| Closed | -$64K | – | 1067 |
|
2019
Q3 | $64K | Buy |
+16,367
| New | +$64K | ﹤0.01% | 1177 |
|